Coromandel International DuPont analysis

Per cent unless marked ×
Tap a line for its trendLast 12Mto Jun 2026FY26Mar 2026FY25Mar 2025FY24Mar 2024FY23Mar 2023FY22 and earlierAlpha Plus
5-step DuPont — ROE = tax burden × interest burden × EBIT margin × turnover × leverage
FY22 and earlierEvery year the company has filed comes with Alpha Plus.
0.72×0.73×0.74×0.74×0.74×
0.95×0.98×1.19×1.02×0.99×
7.9%8.5%9.7%9.8%9.3%
1.45×1.45×1.39×1.47×2.32×
1.87×1.87×1.69×1.68×1.80×
14.8%16.3%19.9%18.3%28.4%
16.6%16.6%20.2%19.0%28.2%
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

COROMANDEL₹1,719.80

Coromandel International Ltd.

· Chemicals
₹ CrorePeersCHAMBLFERTDEEPAKFERTGSFCUPLPIINDSRFSOLARINDSPIDILITINDMcap ₹50,734 Cr
ProfitabilityGrowthCreditLiquidityWorking CapitalYield AnalysisDuPont
Ratios — % unless marked ×
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
5-Step DuPont — ROE = Tax Burden × Interest Burden × EBIT Margin × Turnover × Leverage
Tax Burden (Net Income/Pretax) ×0.740.740.740.730.72
Interest Burden (Pretax/EBIT) ×0.991.021.190.980.95
EBIT Margin %9.269.849.718.527.89
Asset Turnover ×2.321.471.391.451.45
Financial Leverage (Assets/Equity) ×1.801.681.691.871.87
ROE (5-step product, year-end total equity) %28.3718.3519.9016.3114.76
ROE (owners' profit / average owners' equity) %28.2218.9520.1516.5516.55
No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.